Patent details

EP2820048 Title: ANTIBODIES TO MATRIX METALLOPROTEINASE 9

Basic Information

Publication number:
EP2820048
PCT Application Number:
US2012027160
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127084739
PCT Publication Number:
WO2013130078
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES TO MATRIX METALLOPROTEINASE 9
French Title of Invention:
ANTICORPS DIRIGÉS CONTRE LA MÉTALLOPROTÉINASE 9 DE LA MATRICE
German Title of Invention:
ANTIKÖRPER GEGEN MATRIX-METALLOPROTEINASE-9
SPC Number:

Dates

Filing date:
29/02/2012
Grant date:
17/04/2019
EP Publication Date:
07/01/2015
PCT Publication Date:
06/09/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/04/2019
EP B1 Publication Date:
17/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/02/2020
Expiration date:
29/02/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/04/2019
 
 

Name:
Gilead Biologics, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
MCCAULEY, Scott
Address:
United States (US)

2

Name:
SMITH, Victoria
Address:
United States (US)

Classification

IPC classification:
A61K 39/00; C07K 16/40; C12N 9/64; G01N 33/573;

Publication

European Patent Bulletin

Issue number:
201916
Publication date:
17/04/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages